Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes

Abstract This study aimed to detect patients’ characteristics who suffered severe and critical COVID-19 pneumonia admitted to the post-acute COVID-19 rehabilitation clinic in Ankara City Hospital, Physical Medicine and Rehabilitation Hospital and to share our experiences and outcomes of rehabilitation programmes applied. This study was designed as a single-centre, retrospective, observational study. Severe and critical COVID-19 patients, admitted to the post-acute COVID-19 rehabilitation clinic, were included in patient-based rehabilitation programmes, targeting neuromuscular and respiratory recovery. Functional status, oxygen ($ O_{2} $) requirement and daily living activities were assessed before and after rehabilitation. Eighty-five patients, of which 74% were male, were analysed, with the mean age of 58.27 ± 11.13 and mean body mass index of 25.29 ± 4.81 kg/$ m^{2} $. The most prevalent comorbidities were hypertension (49.4%) and diabetes mellitus (34.1%). Of the 85 patients, 84 received antiviral drugs, 81 low-molecular-weight heparin, 71 corticosteroids, 11 anakinra, 4 tocilizumab, 16 intravenous immunoglobulin and 6 plasmapheresis. 78.8% of the patients were admitted to the intensive care unit, with a mean length of stay of 19.41 ± 18.99 days, while those who needed $ O_{2} $ support with mechanic ventilation was 36.1%. Neurological complications, including Guillain–Barré syndrome, critical illness-related myopathy/neuropathy, cerebrovascular disease and steroid myopathy, were observed in 39 patients. On initial functional statuses, 55.3% were bedridden, 22.4% in wheelchair level and 20% mobilised with $ O_{2} $ support. After rehabilitation, these ratios were 2.4%, 4.7% and 8.2%, respectively. During admission, 71 (83.5%) patients required $ O_{2} $ support, but decreased to 7 (8.2%) post-rehabilitation. Barthel Index improved statistically from 44.82 ± 27.31 to 88.47 ± 17.56. Patient-based modulated rehabilitation programmes are highly effective in severe and critical COVID-19 complications, providing satisfactory well-being in daily living activities..

Media Type:

Electronic Article

Year of Publication:




Contained In:

To Main Record - volume:41

Contained In:

Rheumatology international - 41(2021), 12 vom: 27. Sept., Seite 2167-2175




Güler, Tuba [Author]
Yurdakul, Fatma Gül [Author]
Acar Sivas, Filiz [Author]
Kiliç, Zeynep [Author]
Adigüzel, Emre [Author]
Yaşar, Evren [Author]
Bodur, Hatice [Author]


Volltext [lizenzpflichtig]




Inpatient rehabilitation
Neurological manifestations
Patient outcome


© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021



PPN (Catalogue-ID):